Pharmstandard-Ufavita

Pharmstandard-Ufavita is a prominent Russian pharmaceutical manufacturer and a key production subsidiary of the Pharmstandard Group. Based in Ufa, the company operates a large-scale facility dedicated to the development and manufacture of a diverse range of medicinal products, including vitamins, cardiovascular drugs, and advanced biologics. It is notably recognized for its production of genetically engineered human insulin under the Biosulin brand, supporting Russia's national healthcare needs. The facility is fully GMP-compliant and features specialized lines for tablets, ampoules, and lyophilized powders. Pharmstandard-Ufavita plays a critical role in the regional pharmaceutical industry, exporting products across the CIS region. Its long history, dating back to 1916, underscores its established expertise in large-scale pharmaceutical synthesis and formulation.